Hepatic Mesenchymal Hamartoma Combined with Infantile Hepatic Hemangioendothelioma in an Infant  by Hsiao, Kuang-Hung et al.
J Formos Med Assoc | 2007 • Vol 106 • No 3 Suppl S1
CASE REPORT
Hepatic mesenchymal hamartoma and infantile
hepatic hemangioendothelioma are the two most
common benign hepatic tumors of childhood that
account for approximately 50% of cases.1,2 Hepatic
mesenchymal hamartoma usually presents in the
first 2 years of life; abdominal distension is usu-
ally the predominant clinical feature.3,4 Infantile
hepatic hemangioendothelioma is a rare benign
vascular tumor in infants, usually occurring in
infancy with cardiac failure.
Case Report
A female baby was delivered at 39 weeks of gesta-
tion to a G1P1 mother by elective cesarean sec-
tion. At 32 weeks of gestation, a fetal abdominal
mass had been detected by the regular maternal
ultrasound at prenatal follow-up. Soon after birth,
abdominal sonography, computed tomography
(CT), and magnetic resonance cholangiopancre-
atography were performed, and a 3×2.5×2.5 cm
round homogeneous liver cyst over the left medial
section of the liver was noted. Then, the patient
was discharged and received regular follow-up in
the outpatient department. Unfortunately, due to
poor intake with frequent postprandial vomiting,
progressive abdominal distension, and hepato-
megaly, the patient was admitted to our hospital
4 months later.
Abdominal CT was repeated, and it showed an
enlarged 10×9×7 cm liver tumor with a thick wall
involving segment IV of the left lobe and the an-
terior superior segment of the right lobe. In addi-
tion, two new tumors were found over the lateral
segment of the left lobe and another hyperdense
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tumor located over segment VI was noted this time
(Figure 1). Laboratory studies showed that serum
aspartate aminotransferase was 51 IU, and serum
alpha-fetoprotein (AFP) was 6700 ng/mL. Fine
needle aspiration of the cystic hepatic tumor was
performed. The aspirates showed high AFP titer
value (5598 ng/mL), and the cytologic study was
normal. Segmental resection of hepatic segments
IV and VI was then performed (Figure 2), and the
fluid in the cystic tumor was noted to be clear,
thick, and straw colored.
The pathologic diagram of these liver masses
showed mesenchymal hamartoma comprising a
mixture of cysts, bile ducts, hepatocytes, and ede-
matous mesenchymal tissue over the cystic hepatic
tumor and the tumor at the lateral segment of the
left lobe (Figure 3). Beside mesenchymal hamar-
toma, we also found hemangioendothelioma with
numerous small vascular channels lined with
single to multilayered plump endothelial cells
and surrounded by little fibrous stroma over he-
patic segment VI and partial segment IV tumors
(Figure 4). Follow-up abdominal sonogram and
CT scan was performed 1 week after the opera-
tion. Unfortunately, the cystic hepatic tumor had
enlarged (10 × 8 × 5 cm) again. So a complete re-
section of the cystic tumor and left lobectomy
(about 30% of the liver) was performed 21 days
after the initial operation. Pathologic examina-
tion of these liver masses also revealed mesenchy-
mal tissue over the cystic hepatic tumor without
residual or recurrence of hemangioendothelioma.
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Figure 1. Abdominal computed tomography scan of 
4-month-old infant shows an enlarged 10×9×7 cm liver
tumor with thick wall over the quadrate segment of the left
lobe and the anterior superior segment of the right lobe
(double thin arrows). Other tumors include one over the
lateral segment of the left lobe (single thick arrow) and 
another unclear hyperdense one over hepatic segment VI
(single thin arrow).
Figure 2. A 9.5×8×7 cm liver tumor found in the first 
operation.
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Figure 3. (A) Microscopic section reveals mesenchymal hamartoma (hematoxylin & eosin [H & E], 40×). (B) Microscopic
section reveals mesenchymal hamartoma with variable admixture of loose mesenchymal cysts of various sizes and
shapes, branching bile ducts, and hepatocytes (H & E, 100×).
The patient then recovered satisfactorily and the
serum AFP decreased to 859 ng/mL, so she was
discharged 13 days postoperatively. After 7 months
of regular follow-up, she had no evidence of re-
currence, and the AFP level also decreased grad-
ually to 79.5 ng/mL 2 months after the second
operation.
Discussion
Hepatic mesenchymal hamartoma is an uncom-
mon benign lesion. It is the second most common
benign liver tumor seen in children. Clinical symp-
toms usually emerge between 4 months and 
2 years of age.3 The most common presenting
symptom in patients is abdominal distension,
and the most associated complication is respi-
ratory distress from interference with normal
ventilatory mechanics by a large hepatic mass.
Vomiting, fever, constipation, diarrhea, and weight
loss may occur occasionally.4 Our patient was a
female infant, and the major part of the tumor
was in the left lobe of the liver, but in the litera-
ture, mesenchymal hamartoma mostly affects
the right lobe of the liver,4,5 with a slight male
predominance.5
Histologically, mesenchymal hamartoma is
characterized by loose, edematous, mesenchymal
tissue that contains cyst and islands of normal-
appearing hepatocytes and dysmorphic bile 
ductules.6 Liver function tests and AFP values are
usually within normal limits.7 Diagnosis often
relies on the study of the tissue obtained via
biopsy or by tumor resection because laboratory
studies are usually not helpful.8 Recent advances
in genetic research has identified a chromosomal
translocation involving 19q13.4.9 Treatment op-
tions include enucleation, marsupialization, and
surgical resection.6
Infantile hepatic hemangioendothelioma is a
rare liver neoplasm; however, it is the most com-
mon vascular tumor of the liver in the neonate.10
Over 85% of patients develop it in the first 6
months of life, and 45% of cases are associated
with cutaneous hemangioma.10 But our case pres-
ents no other cutaneous hemangioma in the whole
body. It is found more commonly in girls than in
boys. Patients with hepatic hemangioendothe-
lioma can present with abdominal mass, abdom-
inal pain, cutaneous hemangiomas, tachypnea, or
more commonly present with congestive heart
failure.11,12 Histopathologically, they are capillar-
ized vascular channels, lined by one or more lay-
ers of plump endothelial cells.18 In an infantile
hepatic hemangioendothelioma arising from the
liver, the AFP is usually within normal limits, 
although rarely it may be elevated, similar to our
case.13–15
Infantile hepatic hemangioendothelioma usu-
ally resolves on its own within 2 years, and regres-
sion may be accelerated with steroid therapy.16,17
Hepatic mesenchymal hamartoma with hemangioendothelioma in an infant
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Figure 4. (A) Microscopic section reveals hemangioendothelioma (hematoxylin & eosin [H & E], 100×). (B) Microscopic
section reveals hemangioendothelioma with numerous small vascular channels lined by a single layer of bland-appearing,
flattened endothelial cells to multilayered plump endothelial cells and surrounded by little fibrous stroma (H & E, 400×).
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Treatment options include conservative man-
agement, medication (steroid or interferon), ra-
diologic management (selective embolization or
irradiation), and surgery (tumor resection or lig-
ation of feeding vessels).17,18 In our case, hepatic
hemangioendothelioma was resected at the initial
operation, and we found no residual or recurrence
of tumor at the second operation and at the 
5-month follow-up. But we suggest that long-term
follow-up is also needed for the evaluation of
treatment outcome.
In a search of the literature, only one incom-
pletely characterized case was found to share
similar findings like ours.18 It reported that a 
female newborn underwent surgical resection 
for hepatic mesenchymal hamartoma initially.
Unfortunately, 4 months after operation, multi-
ple cutaneous hemangiomas developed and liver
biopsy showed an infantile hemangioendothe-
lioma. An orthotopic liver transplant was per-
formed due to extensive hepatic involvement and
progressive respiratory compromise. In our case,
the essential point is the documentation of the rare
pathologic phenomenon of a concurrent mes-
enchymal hamartoma and infantile hepatic he-
mangioendothelioma in the liver at the same time
with a highly elevated AFP level in the neonatal
period and successful treatment by surgery finally.
So in our opinion, pure chance without any specific
pathobiologic implication accounts for the simul-
taneous presence of mesenchymal hamartoma
and infantile hepatic hemangioendothelioma in
the liver, and total surgical resection of the mes-
enchymal hamartoma and hepatic hemangioen-
dothelioma limited to one lobe is the preferred
treatment option.
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